Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
It looks like the content you wanted summarized didn't come through with your message. Please paste the text, and I'll return the rewritten summary exactly as specified.
Alendronate is a bisphosphonate medication widely prescribed to strengthen bones and reduce fracture risk in osteoporosis. If you’ve been taking alendronate and haven’t seen the expected improvements, you’re not alone. Below, we explore common reasons why alendronate may not be working as intended—and what you can do about it.
Alendronate slows bone breakdown by inhibiting osteoclasts (cells that dissolve bone). Over months to years, this helps:
However, noticeable changes often take 6–12 months on therapy, and full benefits may require 2–3 years of consistent use.
Alendronate’s effectiveness hinges on proper absorption in the stomach and small intestine. Factors that interfere include:
Tips to improve absorption:
Skipping doses or stopping treatment early is a leading cause of “alendronate not working.” Osteoporosis is a chronic condition—missing doses allows bone breakdown to resume. Common adherence challenges:
How to stay on track:
Certain medications and supplements can reduce alendronate’s absorption:
To minimize interactions:
Alendronate is not a quick fix. If you’ve only been on treatment for a few months, BMD improvements may not show up yet on scans. Also, some patients need a higher dose than the standard 70 mg once weekly:
Always follow your doctor’s dosing plan and schedule follow-up bone density tests as recommended.
If alendronate alone isn’t enough, there may be additional factors driving bone loss:
Your doctor may order blood tests, hormone panels or other studies to uncover secondary causes. Treating these underlying issues can make alendronate more effective.
In very rare cases, patients may experience:
If you notice new thigh or groin pain, or jaw pain after dental procedures, speak to your doctor immediately. While these events are uncommon, early evaluation is key.
If you’ve been taking alendronate correctly for at least 12–18 months and still see no improvement—or your bone density has declined—ask your doctor about:
A personalized approach often yields better results than sticking rigidly to one treatment.
Medication works best alongside healthy habits:
• Diet
• Exercise
• Fall prevention
If you suspect alendronate isn’t working—whether due to side effects, persistent bone loss, or unexplained pain—consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you:
Use this tool before your appointment to make the most of your doctor’s time.
Nothing replaces a thorough medical evaluation. If you experience:
please speak to a doctor as soon as possible. If you ever feel that your symptoms could be life-threatening or serious, seek immediate medical care.
By understanding these factors and taking a proactive role in your care, you can optimize bone health and get the most out of your alendronate therapy.
(References)
* Miller PD. New possibilities for diagnosis and treatment of osteoporosis. Int J Fertil Womens Med. 2001 Jul-Aug;46(4):215-21. PMID: 11563832.
* Schmidt LE, Dalhoff K. Food-drug interactions. Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005. PMID: 12093316.
* Miller PD. Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data. Curr Med Res Opin. 2008 Jan;24(1):107-19. doi: 10.1185/030079908x253681. PMID: 18031594.
* Unnanuntana A, Ashfaq K, Ton QV, Kleimeyer JP, Lane JM. The effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res. 2012 Jan;470(1):291-8. doi: 10.1007/s11999-011-1985-9. Epub 2011 Jul 20. PMID: 21773861; PMCID: PMC3237985.
* Hirano D, Chiba K, Yamada S, Ida H. Oral alendronate in pediatric chronic recurrent multifocal osteomyelitis. Pediatr Int. 2017 Apr;59(4):506-508. doi: 10.1111/ped.13236. PMID: 28401741.
* Yu X, Zhang D, Chen X, Yang J, Shi L, Pang Q. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials. J Orthop Sci. 2018 Mar;23(2):356-364. doi: 10.1016/j.jos.2017.12.004. Epub 2017 Dec 29. PMID: 29291916.
* Langdahl B. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches. Bone. 2020 Oct;139:115516. doi: 10.1016/j.bone.2020.115516. Epub 2020 Jul 2. PMID: 32622871.
* Efendioglu EM, Cigiloglu A, Ozturk E, Ozturk ZA. Bone mineral density response to antiosteoporotic drugs in older depressed adults. Arch Osteoporos. 2023 Feb 13;18(1):31. doi: 10.1007/s11657-023-01219-9. Epub 2023 Feb 13. PMID: 36781548.
* Guaraná WL, Lima CAD, Barbosa AD, Crovella S, Sandrin-Garcia P. Farnesyl Diphosphate Synthase Gene Associated with Loss of Bone Mass Density and Alendronate Treatment Failure in Patients with Primary Osteoporosis. Int J Mol Sci. 2024 May 22;25(11). doi: 10.3390/ijms25115623. Epub 2024 May 22. PMID: 38891810; PMCID: PMC11172034.
* Wu J, Zhang S, Lin Y, Jiao J, Fu Z, Hong Q, Zhao Z, Qu X, Su F, Yue B. Targeting a Myeloid-Regulatory B Cell Network Reverses Immune Paralysis in Periprosthetic Joint Infections. Adv Sci (Weinh). 2026 Jun 22;e76149. doi: 10.1002/advs.76149. Epub 2026 Jun 22. PMID: 42325123; PMCID: PMC13336358.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.